saveferris2009
New member
Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial
Pharmaceutical company Pharmaxis (ASX: PXS - News; Nasdaq: PXSL - News) is pleased to announce positive results of its recently completed international Phase III trial of Bronchitol(TM) in people with cystic fibrosis. The study represents one of the largest clinical trials conducted in cystic fibrosis.
<a target=_blank class=ftalternatingbarlinklarge href="http://noexcusesnoexcuses.blogspot.com/search/label/Bronchitol
">http://noexcusesnoexcuses.blog...arch/label/Bronchitol
</a>
read more
Pharmaceutical company Pharmaxis (ASX: PXS - News; Nasdaq: PXSL - News) is pleased to announce positive results of its recently completed international Phase III trial of Bronchitol(TM) in people with cystic fibrosis. The study represents one of the largest clinical trials conducted in cystic fibrosis.
<a target=_blank class=ftalternatingbarlinklarge href="http://noexcusesnoexcuses.blogspot.com/search/label/Bronchitol
">http://noexcusesnoexcuses.blog...arch/label/Bronchitol
</a>
read more